George B. Corcoran Ph.D.

George B. Corcoran Ph.D.

Title

Professor and Senior Advisor for College Research Initiatives

Department

Pharmaceutical Sciences

Office Location

EACPHS, Room 2609

Phone

313-577-1737

Email

corcoran@wayne.edu

George B. Corcoran Ph.D.

Degrees and Certifications

  • 1970 BA Chemistry, Department of Chemistry, Ithaca College, Ithaca, NY
  • 1973 MS Chemistry, Department of Chemistry, Bucknell University, Lewisburg, PA
  • 1980 PhD Pharmacology with Minor In Biochemistry, Department of Pharmacology, School of Medicine, George Washington University, Washington, DC
  • 1981 Postdoctoral Fellowship in Toxicology, Pharmacology/Toxicology Program, Department of Medicine, Baylor College of Medicine, Houston, TX

Positions and Employment

Current positions, titles, affiliations 

1996 Professor, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI (Tenured 1997)
2021 Senior Research Advisor, Eugene Applebaum College of Pharmacy & Health Sciences
1999 Adjunct Professor, Department of Pediatrics, School of Medicine, Wayne State Univ, Detroit, MI
2004 Fellow, Academy of Toxicological Sciences
2002 Associate Editor, Toxicology and Applied Pharmacology
2014 Editor, Journal of Pharmaceutical Sciences and Pharmacology
2014 Editor, MO Journal Toxicology
1997 Member, Graduate Faculty, Wayne State University
1996 Member, Institute for Environmental Health Sciences, Wayne State University
1996 Member, Barbara Ann Karmanos Cancer Institute, Wayne State University
d Applied Pharmacology

Previous positions, titles, affiliations 

1996-21 Chairman, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy &Health Sciences, Wayne State University, Detroit, MI (Tenured 1997)

2018-21 Permanent Member, Federal Insecticide, Fungicide, Rodenticide Act Scientific Advisory Panel, US Environmental Protection Agency

2020-21 Member, Federal Insecticide, Fungicide, Rodenticide Act Scientific Advisory Panel, US EPA: Use of New Approach Methodologies (NAMs) To Derive Extrapolation Factors And Evaluate Developmental Neurotoxicity for Human Health Risk Assessment.

2017 Director of Diversity and Inclusion, Eugene Applebaum College of Pharmacy & Health Sciences
2016 Chair, Council on Diversity and Inclusion, Applebaum College of Pharmacy & Health Sciences
2019-19 Member, Federal Insecticide, Fungicide, Rodenticide Act Scientific Advisory Panel, US EPA:
Quantitative Use of Surface Water Monitoring Data in Pesticide Drinking Water Assessments
2018-18 Member, Federal Insecticide, Fungicide, Rodenticide Act Scientific Advisory Panel, US EPA:
Contact Toxicity - A Case Study Using a New Approach Methodology (NAM)
2018-18 Member, National Toxicology Program Act Scientific Advisory Panel: Technical Reports on Cell
Phone Radiofrequency Radiation Peer Review
2016-17 Associate Dean for Graduate and Public Affairs, Eugene Applebaum College of Pharmacy &
Health Sciences, Wayne State University, Detroit, MI
2016-16 Member, National Toxicology Program Board of Scientific Counselors: Review of Scientific
Programs - Cancer
2015-15 Board Member Representative, National Toxicology Program Report on Carcinogens: Cobalt
2014-15 Co-Chair, National Toxicology Program Review of Laboratory Programs Committee
2014-15 Member, Academy of Toxicological Sciences Executive Board Nominating Committee
2013-14 Member, Academy of Toxicological Sciences Executive Board Awards Committee
2013-14 Postdoctoral Advisory Committee, Wayne State University
2012-16 Member, National Toxicology Program Board of Scientific Counselors
2012-14 Member, Executive Board, Academy of Toxicological Sciences
2012-13 Chair, Executive Board, Council of Scientific Society Presidents
2011-16 Co-Chair, Chairs and Directors Development Workshops Committee, Wayne State University
2011-14 Ex Officio Member, Executive Board, Association of Medical School Pharmacology Chairs
2007-13 Member, Executive Board, Council on Scientific Societies Presidents
2007-13 Member, WSU Clinical Translational Science Award Steering Committee (MACTS)
2007-13 Director, WSU Clinical Translational Science Award Novel Clinical and Translational Methods
2002-12 Member, Editorial Board, Basic and Clinical Pharmacology and Toxicology
2008-11 Member, Scientific Advisory Committee on Alternative Toxicological Methods (SACATM)
2004-10 Visiting Professor, Addis Ababa School of Medicine, Addis Ababa, Ethiopia
2008-09 Past President, Society of Toxicology
2007-08 President, Society of Toxicology
      -First Endowment Fund
      -First Financial Audit Committee
      -New 5-year strategic plan
      -NIH Toxicology Grant Study Section Re-Established
      -Committee for 50th Anniversary Recognition
      -First Consent Agenda
      -First Teleconferences before Council meetings
2006-07 Vice President, Society of Toxicology
2005-06 Vice President-Elect, Society of Toxicology
2004-10 Councilor, International Union of Toxicology
2003-09 Member, US EPA Scientific Advisory Board - Exposure and Human Health Committee
2003-09 Member, US EPA Federal Insecticide, Fungicide and Rodenticide Act Scientific Advisory Panels
2004-06 Member, US EPA Federal Insecticide, Fungicide and Rodenticide Act N-Methyl-Carbamates
Scientific Advisory Panel
2004-06 Member, US EPA Scientific Advisory Board Perfluorooctanoic Acids Scientific Advisory Panel
2003-06 Member, US EPA Scientific Advisory Board PPAR-alpha Scientific Advisory Panel
2003-05 Member, The National Academies Vietnam Education Foundation Fellowships Panel
2002-03 Chairman, National Research Council Hughes Pre-Doctoral Fellowships Neurology & Physiology
1 Panel, The National Academies (Member 2000-03)
2001-03 Secretary, Society of Toxicology
1999-04 Member, Steering Committee, John D. Dingell Veterans Administration Diabetes Research
Enhancement Award Program, Detroit, MI
1998-06 Member, Advisory Board, Children’s Center for Clinical Pharmacology, Children’s Hospital of MI
1996-02 Member, Alcohol Toxicology-1 Study Section, National Institutes of Health, Bethesda, MD
1996-02 Member, Program Leaders Group, Karmanos Cancer Institute, Wayne State, Detroit, MI
2000-01 Secretary-Elect, Society of Toxicology
1999-07 Member, John D. Dingell Veterans Administration Research & Development Committee
1997-99 Member, Scientific Council, American Society for Pharmacology and Experimental Therapeutics
1996-98 Chairman, Division of Toxicology Executive Committee, American Society for Pharmacology and
Experimental Therapeutics
1997-99 Member, Human Genetics Program Advisory Group, Wayne State University
1996-08 Member, National Institute of Environmental Health Sciences Center for Molecular & Cellular
Toxicology with Human Applications, Wayne State University, Detroit, MI
1993-97 Member, Editorial Board, Toxicology Letters
1993-96 Member, Editorial Board, Toxicology and Applied Pharmacology
1993-97 Professor of Pharmacology & Toxicology, Basic Pharmaceutical Sciences, University of New
Mexico College Pharmacy, Albuquerque, NM
1992-98 Member, Editorial Board, Journal of Toxicology and Environmental Health
1989-96 Chairman, Toxicology Graduate Program, University of New Mexico College of Pharmacy,
Albuquerque, NM
1993-96 Adjunct Professor, Department of Biochemistry, University of New Mexico School of Medicine,
Albuquerque, NM
1992-96 Faculty Affiliate, Center on Alcoholism, Substance Abuse, and Addictions, University of New
Mexico, Albuquerque, NM
1990-93 Adjunct Associate Professor, Department of Biochemistry, University of New Mexico School of
Medicine, Albuquerque, NM
1988-93 Associate Professor of Pharmacology and Toxicology, Basic Pharmaceutical Sciences,
University of New Mexico College Pharmacy, Albuquerque, NM (Tenured 1989)
1981-88 Assistant Professor, Department of Pharmaceutics, School of Pharmacy, SUNY at Buffalo,
Buffalo, NY
1980-81 Senior Research Scientist, The Methodist Hospital, Texas Medical Center, Houston, TX
1977-80 Research Assistant, Institute of Lipid Research, Department of Medicine, Baylor College of
Medicine, Houston, TX
1974-77 Chemist (Federal Civil Servant), Laboratory of Chemical Pharmacology, National Heart and Lung
Institute, NIH, Bethesda, MD
1972-74 Guest Worker, Laboratory of Chemical Pharmacology, National Heart and Lung Institute, NIH,
Bethesda, MD
1970-70 Visiting Chemist, Sun Oil Company, Marcus Hook, PA
1970-72 Graduate Teaching Assistant, Department of Chemistry, Bucknell University, Lewisburg PA

 

Awards and Honors

Awards and honors recognizing personal and research group achievement

  • 1967 Freshman Honor Society Awardee, Ithaca College, Ithaca, NY
  • 1968 Dean's List (1967, 1968, 1969), Ithaca College, Ithaca, NY
  • 1970 Graduate Teaching Assistantship, Bucknell University, Lewisburg, PA
  • 1978 ASPET Pre-Doctoral Travel Award Finalist to attend the 7th International Congress on Pharmacology, Paris, France
  • 1981 Searle Scholar Nominee, State University of New York at Buffalo, Buffalo, NY
  • 1983 Searle Scholar Nominee, State University of New York at Buffalo, Buffalo, NY
  • 1984 Session Convener and Chair, 1984 Buffalo Pharmaceutics Symposium, Buffalo, NY
  • 1984 Visiting Professor, International Institute for Infant Nutrition, Buffalo, NY
  • 1987 Visiting Professor, International Institute for Infant Nutrition, Buffalo, NY
  • 1988 Supervised Graduate Student Received Student Poster Award, Mountain West Society of Toxicology, Salt Lake City, UT
  • 1989 Member, Rho Chi Pharmacy National Honor Society
  • 1990 Supervised Graduate Student Received Poster Award, Molecular Biology Section, Society of Toxicology, Miami Beach, FL
  • 1990 Supervised Graduate Student Received Poster Award, Mountain West Soc of Toxicology, Tucson AZ
  • 1991 Norwegian Marshall Fund Award Recipient
  • 1991 Visiting Scientist, Department of Environmental Medicine, National Institute of Public Health, Oslo, Norway
  • 1991 Elected Secretary/Treasurer, Mountain West Society of Toxicology
  • 1992 Director and Chair, Society of Toxicology Placement Committee
  • 1992 Fountain of Youth Award, College of Pharmacy Class of 1992
  • 1993 Certificate of Appreciation, Food and Drug Administration Committee for Advanced Scientific Education, Washington, DC
  • 1993 Elected Treasurer, Mountain West Society of Toxicology
  • 1993 Marshall, College of Pharmacy Commencement, University of New Mexico
  • 1993 Supervised Graduate Student Received Abstract/Manuscript Award, Mechanisms Specialty Section, Society of Toxicology, New Orleans, LA
  • 1993 Supervised Graduate Students (2) Received Outstanding Student Presentation Awards, Southwest and Rocky Mountain Division of the American Association for the Advancement of Science, Abq, NM
  • 1994 Elected Member, Society of Toxicology Education Committee
  • 1994 Vice President, Section on Toxicology, International Union of Pharmacology
  • 1994 Supervised Graduate Student Received Best Graduate Student Poster, International Society for the Study of Xenobiotics, North American Meeting, Tucson, AZ
  • 1994 Biographical Listing: Who's Who in the West
  • 1995 Inaugural Chair, Society of Toxicology Education Sub-Committee on Minority Programs
  • 1995 Teacher of the Year Award, College of Pharmacy, University of New Mexico, Albuquerque, NM
  • 1995 Nominee, Outstanding Teacher of the Year Award, University of New Mexico, Albuquerque, NM
  • 1995 Recognized by American Association of Colleges of Pharmacy as 1995 Teacher of the Year at Annual Meeting, Philadelphia, PA
  • 1996 Biographical Listing: Five Thousand Personalities of the World
  • 1996 Member of Executive Committee, Division of Toxicology, American Society for Pharmacology and Experimental Therapeutics
  • 1996 Marshall, College of Pharmacy Commencement
  • 1996 Elected Vice President-Elect, Mountain West Society of Toxicology
  • 1996 Elected Councilor, Mechanisms Specialty Section, Society of Toxicology
  • 1996 Chair, Education Committee, Society of Toxicology
  • 1996 Biographical Listing: Who's Who in Medicine and Healthcare
  • 1996 Chairman, Division of Toxicology Executive Committee, American Society for Pharmacology and Experimental Therapeutics
  • 1997 Supervised Graduate Student Received Popejoy Outstanding Dissertation Award for the Best Dissertation in Life/Physical Sciences and Engineering Between 1994-1997 at the University of New Mexico, Albuquerque, NM
  • 1998 Member, Volwiler Award Committee of the American Association of Colleges of Pharmacy
  • 2000 Secretary Elect, Society of Toxicology
  • 2005 Member, Volwiler Award Committee of the American Association of Colleges of Pharmacy
  • 2004 Elected Fellow, Academy of Toxicological Sciences

Professional Memberships

Memberships, fellowships, and offices held in professional organizations

  • 1966 Zeta Sigma Nu Honor Society
  • 1968 American Chemical Society (Student Affiliate - Currently Inactive)
  • 1982 American Association for the Advancement of Science (Currently Inactive)
  • 1984 Pharmacy School Pharmacologists (Currently Inactive)
  • 1986 American Association of Pharmaceutical Scientists (Charter Member, Currently Inactive)
  • 1987 American Society for Pharmacology and Experimental Therapeutics Scientific Council
    • Member (1997-9)
    • Division of Drug Metabolism: Member (1988-)
    • Division of Toxicology: Member (1991-)
    • Division of Toxicology Executive Committee: Chair (1997-9), Member (1996-00)
  • 1988 Society of Toxicology
    • Board of Directors (Council), Chair (2007-2008), Member (2001-2004; 2005-2009)
    • Congressional Subcommittee, Chair (2008-2013), Member (2007-date)
    • Nominating Committee, Chair (2009), Member (2013-14)
    • Undergraduate Education Strategic Work Group, Member (2012-Date)
    • Endowment Fund Board, Member (2007-2010)
    • Finance Committee, Member (2006-2009)
    • Board of Publications, Member (2006-2009); Marketing Subcommittee (2006-2009)
    • Membership Services Strategy Committee, Council Liaison (2006-2007)
    • Nominating Committee, Council Liaison (2005-2006)
    • Program Committee, Chair (2006-2007), Co-Chairman (2005-2006)
    • Post-Doctoral Fellow Task Force, Council Liaison (2005-2006)
    • Placement Committee, Chair (1992-193); Member (1990-1993); Volunteer (1989-1990)
    • Education Committee, Chair (1995-1996); Member (1993-1996)
    • Sub-Committee on Community Outreach, Member (1996-1998)
    • Subcommittee on Minority Education Initiatives, Inaugural Chair (1995-1996)
    • Mechanisms Specialty Section Elected Councilor (1996-1998), Member (1988-Date)
    • Regulatory and Safety Evaluation Specialty Section Member (1993-Date)
  • 1988 Mountain West Chapter of the Society of Toxicology
    • Vice President Elect (1996-7)
    • Treasurer (1993-4)
    • Secretary/Treasurer (1991-3)
    • Local Organizing Comm Chairperson (1989)
    • Awards Committee (1990, 1994)
    • Member (1988-97)
  • 1997 Michigan Chapter of the Society of Toxicology Member (1997-)
  • 1988 American Association of Colleges of Pharmacy (1992-), Volwiler Award Committee Member (1997-8)
  • 1993 International Union of Pharmacology Section on Toxicology, Vice President (1994-1998), President (1998-02)
  • 1999 Michigan Pharmacists Association Member (1999-Date)
  • 2004 International Union of Toxicology
    • Candidate, Secretary-General (2004, 2007)
    • Councilor (2005-2008, 2008-2011)

 

OTHER SERVICE TO THE PROFESSION (Also See Present and Past Affiliations)

 

International Union of Toxicology
  Candidate, Secretary-General (2004, 2007)
  Councilor (2005-2008, 2008-2011)


Society of Toxicology
  Member, Board of Directors (Council) (2001-2004; 2005-2009)
  Founding Chair Congressional Subcommittee, (2008-2013), Member (2007-2018)
  Chair, Nominating Committee (2009), Member (2013-14)
  Member, Undergraduate Education Strategic Work Group, Member (2012-14)
  Member, Endowment Fund Board, Member (2007-2010)
  Member, Finance Committee, Member (2006-2009)
  Member, Board of Publications, Member (2006-2009); Marketing Subcommittee (2006-2009)
  Membership Services Strategy Committee, Council Liaison (2006-2007)
  Council Liaison, Nominating Committee, (2005-2006)
  Chair, Program Committee (2006-2007), Co-Chair (2005-2006)
  Council Liaison, Post-Doctoral Fellow Task Force (2005-2006)
  Chair, Placement Committee (1992-193); Member (1990-1993); Volunteer (1989-1990)
  Chair, Education Committee (1995-1996); Member (1993-1996)
  Member, Sub-Committee on Community Outreach (1996-1998)
  Inaugural Chair, Subcommittee on Minority Education Initiatives (1995-1996)
  Member, Women in Toxicology Awards Ad Hoc Nomination Committee (2020)
  Workshop Co-Organizer / Co-Chair, Cannabidiol Science, Safety and Society: Where do we
stand? (2021)
  Workshop Co-Organizer / Co-Chair, Cannabidiol Science, Safety and Society: Where do we
stand? 2020 (Postponed)
  Workshop Co-Organizer / Co-Chair, Medical Marijuana: Issues Facing the Regulatory, Medical, and
Academic Environments (2018)
  Workshop Organizer / Chair, Cannabis in the Courtroom (2016)
  Workshop Organizer / Chair, Skeptically Re-Examining the Limits of Toxicology Evidence in the
Courtroom (2014)
  Roundtable Organizer / Chair, Skeptically Examining the Limits of Toxicological Evidence in the
Courtroom (2013)
  Symposium Organizer, Chair, Implications or Reactive Intermediates, Salt Lake (2010)
  Symposium Organizer, Chair, Metabolic Syndrome and DILI, Salt Lake (2010)
   Symposium Organizer, Chair, Obesity as a Modulator of Chemical Toxicity, San Diego (2006)
  Platform Session Chair, Apoptosis, Philadelphia, PA (2000)
  Platform Session Chair, Oxidative Stress, Miami Beach, FL (1990)
  Platform Session Chair, Glutathione Conjugates and Bioactivation, Seattle, WA (1992)
  Symposium Organizer / Chair, Apoptosis: Molecular Control of Toxicity, New Orleans, LA (1993)
  Poster Discussion Session Chair, Xenobiotic-Induced Apoptosis, Dallas, TX (1994)
  Poster Session Chair, Carcinogenesis, Baltimore, MD (1995)
  Platform Session Chair, Molecular/Cellular, Anaheim, CA (1996)
  Poster Discussion Chair, Molecular Aspects of Oxidative Stress, Cincinnati, OH (1997)


Mechanisms Specialty Section
  Elected Councilor (1996-1998)
  Member (1988-Date)


Regulatory and Safety Evaluation Specialty Section
  Member (1993-Date)


Mountain West Society of Toxicology
  Chair, Poster Discussion (1994)
  Treasurer (1993-1994)
  Secretary/Treasurer (1991-1993)
  Vice President-Elect (1996-1997)
  Chair, Local Arrangements Committee (1989-1990)
  Member (1988-1996)

American Society for Pharmacology and Experimental Therapeutics
  Member, Scientific Council (1997-1999)
  Chair, Division of Toxicology Executive Committee (1996-1998)
  Federation of American Societies for Experimental Biology
  Co-Chair, Drug Metabolism and Toxicity II, Las Vegas, NV (1988)
  Platform Session Chair, Toxicology I, Atlanta, GA (1991)
  American Association for the Advancement of Science
  Symposium Chair, Obesity as a modifier of chemical toxicity, San Francisco, CA (2007)
  Symposium Co-Chair, Cannabidiol Science, Safety and Society: Where do we stand? (virtual 2021)


Continuing Education
  Speaker, Cardiovascular Disease, University of New Mexico (1989)
  Invited Course Lecturer
  Advanced Pathology/Toxicology, Dept Pathology, U Texas Medical Branch, Galveston, TX (1992)
  Advanced Principles Toxicology, Dept Pharmacol/Toxicology, Michigan State U, E Lansing, MI (1998-00)

External Promotion & Tenure Reviews
  45 Reviews for 28 Universities

 

 

Primary Research Interest

Research interests are multidisciplinary and translational. They focus on cellular injury and cell death, as well as factors governing drug and chemical-induced injuries, including drug metabolism and nutrition. Approaches designed to translate basic discoveries to improve human health involve integrated in vivo models, cellular and molecular biology, pharmacokinetics, synthetic chemistry, and retrospective and prospective clinical investigation of human volunteers and patients. Specific areas of investigation include cell death by necrosis and apoptosis, the role of DNA damage in acute cell death, drug and chemical injury to the liver, role of nutrition and obesity in drug and chemical injury, drug biotransformation including by CYPs, and particularly the toxicity of acetaminophen (paracetamol).

Recent Publications

  1. Corcoran GB: Reactions of a 1-Aza-3-azoniabicyclo[3.1.0]hex-3-ene salt and its derivatives. Master of Science Thesis, Bucknell University, Lewisburg, PA, 1973.
  2. Corcoran GB: Mechanism of protection against acetaminophen-induced hepatic necrosis by N-acetylcysteine and other sulfhydryl nucleophiles. Doctor of Philosophy Dissertation, George Washington University, Washington, DC, 1980.
  3. Heine HW, Newton TA, Blosick GJ, Irving KC, Meyer C, Corcoran GB: Aziridines. XXVI. Reactions of 1,3-diazabicyclo-[3,1,0]-hex-3-enes. J Org Chem 38: 651-654, 1973.
  4. Nelson SD, Mitchell JR, Timbrell JA, Snodgrass WR, Corcoran GB: Isoniazid and iproniazid: Activation of metabolites to toxic intermediates in man and rat. Science 193: 901-903, 1976.
  5. Mitchell JR, Corcoran GB: Macromolecular binding in assessing drug and chemical-induced tissue lesions. J Environ Pathol Toxicol 1: 101-115, 1977.
  6. Corcoran GB, Mitchell JR, Vaishnav YN, Horning EC, Nelson SD: Formation of chemically reactive metabolites from drugs. In: Advances in Pharmacology and Therapeutics: Toxicology, JR Boissier, P Lechat, J Fichelle, eds, Vol 9, Pergamon Press, Oxford, pp 103-111, 1978.
  7. Mitchell JR, Corcoran GB: Pharmacological and toxic reactions in adult and pediatric medicine. In: Clinical Pharmacology and Therapeutics: A Pediatric Perspective, BL Mirkin, ed, Year Book Medical Publishers, Inc, Chicago, pp 49-58, 1978.
  8. Mitchell JR, Corcoran GB, Lauterburg BH, Smith CV, Horning EC: Alkylating and non-alkylating reactive metabolites formed from toxic drugs. In: The Liver: Quantitative Aspects of Structure and Function, R Preisig, J Bircher, eds, Edito Cantor, Aulendorf, pp 269-279, 1979.
  9. Corcoran GB, Mitchell JR, Vaishnav YN, Horning EC: Evidence that acetaminophen and N-hydroxy-acetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. Molec Pharmacol 18: 536-542, 1980.
  10. Mitchell JR, Corcoran GB, Hughes H, Lauterburg BH, Smith CV: Acute lethal liver injury caused by chemically reactive metabolites. In: Chemical Indices and Mechanisms of Organ-Directed Toxicity, SS Brown, DS Davies, eds, Pergamon Press, Oxford, pp 117-129, 1981.
  11. Mitchell JR, Corcoran GB, Smith CV, Hughes H, Lauterburg BH, Nelson EB: Acetaminophen metabolism and toxicity. In: Drug Reactions and the Liver, M Davis, J Tredger, R Williams, eds, Plenum Press, London, pp 130-143, 1981.
  12. Corcoran GB, Mitchell JR: Evidence for redox cycling of acetaminophen and its reactive metabolite by endogenous microsomal systems. In: Biological Reactive Intermediates -II, R Snyder, DV Parke, JJ Kocsis, DJ Jollow, GG Gibson, CM Witmer, eds, Plenum Press, New York, pp 1085-1098, 1982.
  13. Mitchell JR, Corcoran GB, Smith CV, Hughes H, Lauterburg BH: Alkylation and peroxidation injury from reactive metabolites. In: Biological Reactive Intermediates - II, R Snyder, DV Parke, JJ Kocsis, DJ Jollow, GG Gibson, CM Witmer, eds, Plenum Press, New York, pp 199-223, 1982.
  14. Lauterburg BH, Corcoran GB, Mitchell JR: Mechanism of action of N-acetylcysteine in protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 71: 980-991, 1983.
  15. Mitchell JR, Smith CV, Lauterburg BH, Hughes H, Corcoran GB, Horning EC: Reactive metabolites and the pathophysiology of acute lethal cell injury. In: Drug Metabolism and Drug Toxicity, JR Mitchell, MG Horning, eds, Raven Press, New York, pp 301-319, 1984.
  16. Corcoran GB, Todd EL, Racz WJ, Hughes H, Smith CV, Mitchell JR: Effects of N-acetylcysteine on metabolism and disposition of acetaminophen in mice. J Pharmacol Exp Ther 232: 857-63, 1985.
  17. Corcoran GB, Racz WJ, Smith CV, Mitchell JR: Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice. J Pharmacol Exp Ther 232: 864-872, 1985.
  18. Galinsky RE, Corcoran GB: Influence of advanced age on the formation and elimination of acetaminophen metabolites by male rats. Pharmacology 32: 313-320, 1986.
  19. Corcoran GB, Wong BK: Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: Studies with N-acetyl-D-cysteine in mice. J Pharmacol Exp Ther 238: 54-61, 1986.
  20. Wong BK, Galinsky RE, Corcoran GB: Dissociation of increased sulfation from sulfate replenishment and hepatoprotection in acetaminophen poisoned mice by N-acetylcysteine stereoisomers. J Pharmaceut Sci 75: 878-880, 1986.
  21. Corcoran GB: Pharmacokinetic considerations in total parenteral nutrition. In: Total Parenteral Nutrition: Indications, Utilization, Complications, and Pathophysiological Considerations, E Lebenthal, ed, Raven Press, New York, pp 125-140, 1986.
  22.  McLean AJ, Lalka D, Corcoran GB, Melander A: Drug-nutrient interactions. In: Recent Advances in Clinical Nutrition: 2, ML Wahlqvist, AS Truswell, eds, John Libby & Sons, London, pp 1-8, 1986.
  23. Wong BK, U S-WE, Corcoran GB: An overfed rat model that reproduces acetaminophen disposition in obese humans. Drug Metab Dispos 14: 674-679, 1986.
  24. Wong GB, Chan HC, Corcoran GB: Selective effects of N-acetylcysteine stereoisomers on hepatic glutathione and plasma sulfate in mice. Toxicol Appl Pharmacol 86: 421-429, 1986.
  25. Wong BK, Corcoran GB: Effect of esterase inhibitors and buthionine sulfoximine on the prevention of acetaminophen hepatotoxicity by N-acetylcysteine. Res Comm Chem Pathol Pharmacol 55: 397-408, 1987.
  26. Corcoran GB, Wong BK, Shum L, Galinsky RE: Acetaminophen sulfation deficit in obese rats overfed an energy-dense Cafeteria diet. Endocr Res 13: 101-121, 1987.
  27. Corcoran GB, Wong BK: Obesity as a risk factor in drug-induced organ injury: Increased liver and kidney damage by acetaminophen in the obese overfed rat. J Pharmacol Exp Ther 241: 921-7, 1987.
  28. Corcoran GB, Chung S-J, Salazar DE: Early inhibition of plasma membrane sodium ion transport during acetaminophen hepatotoxicity. Biochem Biophys Res Comm 149: 203-207, 1987.
  29. Corcoran GB, Wong BK, Neese BL: Early sustained rise in total liver calcium during acetaminophen hepatotoxicity in mice. Res Comm Chem Pathol Pharmacol 58: 291-304, 1987.
  30. Galinsky RE, Corcoran GB: Suppression of acetaminophen conjugation and conjugate elimination in rat by metyrapone, a classical cytochrome P-450 inhibitor. Drug Metab Dispos 16: 348-54, 1988.
  31. Corcoran GB, Bauer JA, Lau T-WD: Immediate rise in intracellular calcium and glycogen phosphorylase a activities during acetaminophen covalent binding leading to hepatotoxicity in mice. Toxicology 50: 157-167, 1988.
  32. Salazar DE, Corcoran GB: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Amer J Med 84: 1053-1060, 1988.
  33. Corcoran GB, Salazar DE: Obesity as a risk factor in drug-induced organ injury II Increased renal cytochrome P-450 in the obese overfed rat. Drug Metab Dispos 16: 898-900, 1988.
  34. Corcoran GB, Salazar DE, Schentag JJ: Excessive aminoglycoside nephrotoxicity in obese patients. Amer J Med 85: 279, 1988.
  35. Salazar DE, Sorge CL, Corcoran GB: Obesity as a risk factor in drug-induced organ injury. VI. Increased hepatic P450 concentration and microsomal ethanol oxidizing activity in the overfed rat. Biochem Biophys Res Comm 157: 315-320, 1988.
  36. Matsumoto RM, Jusko WJ, Corcoran GB: In vitro hepatic drug metabolism in an overfed rat model of human obesity. Drug-Nutr Interact 5: 237-247, 1988.
  37. Corcoran GB, Salazar DE, Chan HH: Obesity as a risk factor in drug-induced organ injury. III. Increased liver and kidney injury by furosemide in the obese overfed rat. Toxicol Appl Pharmacol8: 12-24, 1989.
  38. Corcoran GB, Salazar DE, Sorge CL: Pharmacokinetic characteristics of the obese overfed rat. Intl J Obesity 13: 69-79, 1989.
  39. Corcoran GB, Salazar DE: Obesity as a risk factor in drug-induced organ injury IV Increased gentamicin nephrotoxicity in the obese overfed rat. J Pharmacol Exp Ther 248: 17-22, 1989.
  40. Corcoran GB, Salazar DE: Pharmacological considerations in childhood obesity. In: Textbook of Gastroenterology and Nutrition in Early Childhood, E Lebenthal, ed, Raven Press, New York, NY, pp 75-86, 1989.
  41. Wong BK, Corcoran GB: N-Acetylcysteine stereoisomers as in vivo probes of the role of glutathione in drug detoxification. In: Handbook of Glutathione: Metabolism and Physiological Functions, J Via, ed, CRC Press, Boca Raton, FL, pp 255-262, 1990.
  42. Ray SD, Sorge CL, Raucy JL, Corcoran GB: Early loss of genomic DNA in vivo with accumulation of Ca2+ in the nucleus during acetaminophen-induced liver injury. Toxicol Appl Pharmacol 106: 346-351, 1990.
  43. Griener JC, Msall ME, Cooke RE, Corcoran GB: Noninvasive determination of acetaminophen disposition in Down's syndrome. Clin Pharmacol Ther 48: 520-8, 1990.
  44. Ray SD, Sorge CL Tavacoli, A Raucy, JL, Corcoran GB: Extensive alteration of genomic DNA and rise in nuclear Ca2+ in vivo after hepatotoxic acetaminophen overdose in mice." In: Biological Reactive Intermediates IV Molecular and Cellular Effects and Their Impact on Human Health, DJ Jollow, R Snyder, IG Sipes, eds, Plenum Press, New York, pp 699-705, 1991.
  45. Raucy JL, Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB: Induction of P450IIE1 in the obese overfed rat. Molec Pharmacol 39: 275-280, 1991.
  46. Shen W, Kamendulis LM, Ray SD, Corcoran GB: Acetaminophen-induced cytotoxicity in cultured mouse hepatocytes: Correlation of nuclear Ca2+ accumulation and early DNA fragmentation with cell death. Toxicol Appl Pharmacol 111: 242-254, 1991.
  47. Corcoran GB, Ray SD: Damage to the nucleus and acute cell death produced by alkylating hepatotoxins. In: Molecular Theories of Cell Life and Death, S Ji, ed, Rutgers University Press, New Brunswick, NJ, pp 384-400, 1991.
  48. Shen W, Kamendulis LM, Ray SD, Corcoran GB: Acetaminophen-induced cytotoxicity in cultured mouse hepatocytes: Effects of Ca2+-endonuclease, DNA repair, and glutathione depletion inhibitors on DNA fragmentation and cell death. Toxicol Appl Pharmacol 112: 32-40, 1992. http://www.ncbi.nlm.nih.gov/pubmed/1310169
  49. Burchiel SW, Davis DP, Ray SD, Sorge CL, Archuleta M, Thilsted J, Corcoran GB: DMBA-Induced cytotoxicity in lymphoid and nonlymphoid organs of B6C3F1 mice: relation of cell death to target cell intracellular calcium and DNA damage. Toxicol Appl Pharmacol 13: 126-132, 1992. http://www.ncbi.nlm.nih.gov/pubmed/1553745
  50. Salazar DE, Corcoran GB: Obesity as a risk factor in drug-induced organ injury V Increased renal uptake of gentamicin in the obese overfed rat. Drug Metab Dispos 20: 402-406, 1992. http://www.ncbi.nlm.nih.gov/pubmed/1355715
  51. Corcoran GB, Ray SD: Contemporary Issues - The role of the nucleus and other compartments in acute cell death produced by alkylating hepatotoxicants. Toxicol Appl Pharmacol 113: 167-83, 1992. http://www.ncbi.nlm.nih.gov/pubmed/1561626
  52. Ray SD, Sorge CL, Kamendulis LM, Corcoran GB: Ca2+-Activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: Effects of Ca2+-endonuclease and poly(ADP-Ribose) polymerase inhibitors in mice. J Pharmacol Exp Ther 63: 387-394, 1992. http://jpet.aspetjournals.org/content/263/1/387.long
  53. Kamendulis LM, Corcoran GB: Independence and additivity of cultured hepatocyte killing by Ca2+ overload and ATP depletion. Toxicol Lett 63: 277-287, 1992. http://www.sciencedirect.com/science/article/pii/0378427492900907
  54. Ray SD, Kamendulis LM, Gurule MW, Yorkin RD, Corcoran GB: Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 7: 453-463, 1993. http://www.fasebj.org/cgi/reprint/7/5/453
  55. Kraner JC, Lasker JM, Corcoran GB, Ray SD, Raucy JL: Induction of P450IIE1 by acetone in isolated rabbit hepatocytes involves increased protein synthesis. Biochem Pharmacol 45: 1483-1492, 1993. http://www.ncbi.nlm.nih.gov/pubmed/8471070
  56. Ramzan I, Wong BK, Corcoran GB: Pain sensitivity in dietary-induced obesity. Physiol Behav 54: 433-435, 1993. http://www.sciencedirect.com/science/article/pii/0031938493902314
  57. Salazar DE, Sorge CL, Jordan SW, Corcoran GB: Obesity decreases hepatic glutathione and increases allyl alcohol-induced periportal necrosis in the obese overfed rat. Intl J Obesity 18: 25-33, 1994. http://www.ncbi.nlm.nih.gov/pubmed/8130812
  58. Corcoran GB, Fix LF, Jones DP, Moslen MT, Nicotera P, Oberhammer FA, Buttyan R: Contemporary Issues. Apoptosis: Molecular control point in toxicity. Toxicol Appl Pharmacol 128: 169-181, 1994. http://www.sciencedirect.com/science/article/pii/S0041008X84711951
  59. Kamendulis LM, Corcoran GB: DNA as a critical target in toxic cell death: potentiation of dimethylnitrosamine toxicity in cultured mouse hepatocytes by DNA repair inhibitors. J Pharmacol Exp Ther 271: 1695-1698, 1994. http://jpet.aspetjournals.org/content/271/3/1695.long
  60. Fischer-Nielsen A, Corcoran GB, Poulsen HE, Kamendulis LM, and Loft S: Menadione induced DNA fragmentation without 8-hydroxy-2'-deoxyguanosine formation in isolated rat hepatocytes. Biochem Pharmacol 49: 1469-1474, 1995. http://www.sciencedirect.com/science/article/pii/000629529400525Q
  61. Kamendulis LM, Shen W, Ray SD, Corcoran GB: Dimethylnitrosamine-induced cytotoxicity in cultured mouse hepatocytes. J Toxicol Environ Health 46: 31-46, 1995. http://www.ncbi.nlm.nih.gov/pubmed/7666492
  62. Johnston DE, Marcadis D, Corcoran GB, DeBetta M, Salas VM, Ramos HC: Purification of primary human hepatocytes using Ricin A chain. In Vitro Cell Dev Biol 32: 388-390,1996. http://link.springer.com/article/10.1007/BF02722998#page-2
  63. Salas VM, Corcoran GB: Ca2+-Dependent DNA damage and cAMP-independent glycogen phosphorylase activation in an in vitro model of acetaminophen-induced liver injury. Hepatology 25: 1432-1438, 1997. http://www3.interscience.wiley.com/cgi-bin/fulltext/106594724/PDFSTART
  64. Bezin L, Anastasiadis PZ, Corcoran GB, Nygaard TG, Levine RA: Tetrahydrobiopterin metabolism in cell death by apoptosis. In: Chemistry and Biology of Pteridines and Folates, H Rokos and W Pfleiderer (Eds), Blackwell Publishers, Berlin, pp 747-754, 1997.
  65. Groc L, Jackson-Hunter T, Jiang H, Bezin L, Koubi D, Corcoran GB, and Levine RA: Nitric oxide synthase inhibition during development: effect on apoptotic death of dopamine neurons. Dev Brain Res 138: 147-153, 2002. http://www.sciencedirect.com/science/article/pii/S0165380602004649
  66. Jiang H, Koubi D, Groc L, Hunter T, Anastasisdis P, Rodriguez A, Corcoran GB, Levine R: The role of tetrahydrobiopterin (BH4) in apoptosis of catecholamine (PC12) cells induced by trophic factor withdrawal. In: Chemistry &Biology of Pteridines & Folates, S. Milstien, G. Kapatos, R. Levine and B. Shane (Eds), Kluwer Academic Publishers, Boston/Dordrecht/London, pp 405-408, 2002.
  67. Koubi D, Jiang H, Hunter T, Anastasisdis PZ, Rodriguez AI, Corcoran GB, Levine RA. The involvement of tetrahydrobiopterin in ischemia-induced apoptosis. In: Chemistry and Biology of Pteridines and Folates, S. Milstien, G. Kapatos, R.A. Levine and B. Shane (Eds), Kluwer Academic Publishers, Boston-Dordrecht-London, pp. 409-413, 2002.
  68. Koubi D, Jiang H, Hunter T, Rodriguez AI, Corcoran GB, Levine RA: Tetrahydrobiopterin (BH4) mediates necrotic death of PC12 cells exposed to ischemia-like conditions. In: Pterins, Folates, and Neurotransmitters in Molecular Medicine, SPS Verlagsgesellscraft mbH, Heilbronn, Germany, pp. 35-40, 2003.
  69. Leslie SW, Corcoran GB, MacKichan JJ, Undie AS, Vanderveen RP, Miller KW. Pharmacy Scholarship Reconsidered: The Report of the 2003-2004 Research and Graduate Affairs Committee. Am J Pharm Educ 68: S6, 2004.http://www.aacp.org/governance/COMMITTEES/reasearchgraduateaffairs/Documents/2003%20to%202004%20Research%20and%20Graduate%20Affairs%20Committee.pdf
  70. Koubi D, Jiang H, Zhang L, Tang W, Kuoa J, Rodriguez AI, Jackson-Hunter T, Seidman MD, Corcoran GB, Levine RA: Role of the Bcl-2 family of proteins in mediating apoptotic death of PC12 cells exposed to oxygen and glucose deprivation. Neurochem Intl 46: 73-81, 2005.http://www.sciencedirect.com/science/article/pii/S0197018604001238
  71. Jiang H, Zhang L, Kuo J, Kuo K, Gautam SC, Groc L, Rodriguez AI, Koubi D, Hunter TJ, Corcoran GB, Seidman MD, Levine RA. Resvetratrol-induced apoptotic cell death in human U251 glioma cells. Mol. Cancer Therapeutics 4: 554-561, 2005. http://mct.aacrjournals.org/content/4/4/554.long
  72. Corcoran GB. Obesity as an Occult Risk Factor in Drug- and Chemical-Induced Toxicities. In: “Phytopharmaceuticals for Obesity Treatment: Pathophysiology and Weight Management," Debasis Bagchi and Harry Preuss, eds., CRC Press, Boca Raton, FL, pp 165-173, 2007.
  73. Ray SD, Corcoran GB. Cell death and apoptosis. In: "General and Applied Toxicology," B. Ballantyne, T. Marrs and T. Syversen, Eds, Nature Publishers, Vol 1, pp. 247-312, 2009.
  74. Patel N, Joseph C, Corcoran GB, Ray SD. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL, and p53 expression while preventing apoptotic and necrotic death in the liver. Toxicol Appl Pharmacol 245: 143-152, 2010. http://www.sciencedirect.com/science/article/pii/S0041008X10000451
  75. Hirata A, Corcoran GB, Hirata F: Carcinogenic heavy metals replace Ca2+ for DNA binding and annealing activities of mono-ubiquitinated annexin A1 homodimer. Toxicol Appl Pharmacol 248: 45-51, 2010. http://www.sciencedirect.com/science/article/pii/S0041008X10002310
  76. Hirata A, Corcoran GB, Hirata F: Carcinogenic heavy metals As3+ and Cr6+ increase nuclear mono-ubiquinated annexin A1 affinity for DNA containing 8-oxo-guanosine and promote translesion DNS synthesis Toxicol Appl Pharmacol 252: 159-164, 2011. http://www.sciencedirect.com/science/article/pii/S0041008X10002310
  77. Ismail S, Tathod J, Parmar M, Corcoran GB, Ray SD: Matrix metalloproteinase-9, -10, and -12, MDM2 and p53 expression in mouse liver during dimethylnitrosamine-induced oxidative stress and genomic injury. Molec Cell Biochem 365: 351-61, 2012 http://link.springer.com/article/10.1007%2Fs11010-012-1277-z
  78. Corcoran GB. The obese and overweight: A new sensitive population for drug and chemical toxicities ?. In: "Obesity: Epidemiology, Pathophysiology and Prevention," Debasis Bagchi and Harry Preuss, eds., 2nd Edition, CRC Press, Boca Raton, FL, pp 263-274, 2012.
  79. Hirata F, Corcoran GB, Hirata A: “Mono-Ubiquitination of Nuclear Annexin A1 and Mutagenesis,” In: Mutagenesis, Rajnikant Mishra, Editor, Intech, 2012. http://dx.doi.org/10.5772/50800
  80. S. Betharia, F. F. Farris, G. B. Corcoran and S. D. Ray. ‘Mechanisms of Toxicity’ In: Wexler, P. (Ed.), Encyclopedia of Toxicology, 3rd edition vol 3. Elsevier Inc., Academic Press, pp. 165-175, 2014. http://www.sciencedirect.com/science/article/pii/B9780123864543003298
  81. Corcoran GB, and Ray SD. ‘Benzyl Alcohol’ In: Wexler, P. (Ed.), Encyclopedia of Toxicology, 3rd edition vol 3. Elsevier Inc., Academic Press, pp. 429-432, 2014 http://www.sciencedirect.com/science/article/pii/B9780123864543002517
  82. Hirata A, Harada T, Corcoran GB, Hirata F: Inhibitory effects of flavonoids on nuclear mono-ubiquitinated annexin A1 helicase activity and mutation of the thymidine kinase gene in L5178 th(+/-) cells. Mutat Res Fundam Mol Mech Mutagen 759: 29-36, 2014.http://www.ncbi.nlm.nih.gov/pubmed/?term=Hirata+A%2C+Harada+T%2C+Corcoran+GB%2C+Hirata+F%3A+Inhibitory+effects+of+flavonoid
  83. Corcoran GB (2011): The Advance of Safety Sciences Including Understanding Threat of Overnutrition and Obesity to Human Health” Council of Scientific Society Presidents Spring Meeting, The American Chemical Society, Washington, DC.
  84. Corcoran GB (2012): Drugs and Toxic Chemicals: A Lurid Morality Tale for Lawyers and Experts. Program of the State Bar Association of New Mexico Continuing Legal Education Course entitled Skeptically Examining the Limits of Expert Testimony and Evidence, Albuquerque, NM.
  85. Corcoran GB, Norman J, Saks MJ, Bobst SM, and Kennedy RT (2013): Skeptically Examining the Limits of Toxicology Evidence in the Courtroom.” Society of Toxicology 52nd Annual Meeting and ToxExpo, San Antonio, TX, The Toxicologist, Oxford University Press, 2041, 2013.
  86. Corcoran GB, Saks MJ, Bobst SM, Marchant GE, Simon T, and Kennedy RT: Skeptically Re-Examining the Limits of Toxicology Evidence in the Courtroom. Society of Toxicology 53rd Annual Meeting and ToxExpo, Phoenix, AZ, The Toxicologist, Oxford University Press, 719, 2014.
  87. Corcoran GB, Bobst SM, Schneider K, Barrie M, Hoyte C, Plunkett LM, and Kennedy RT: “Cannabis in the Courtroom.” Society of Toxicology 55th Annual Meeting and ToxExpo, New Orleans, LA, The Toxicologist, Oxford University Press, 2519a, 2016.
  88. Corcoran GB, Bobst S, Plunkett LM, Kaplan B, Janus E, and Hoyte C: Marijuana Safety: Issues Facing the Regulatory, Medical, and Academic Environments. Society of Toxicology 57th Annual Meeting and ToxExpo, San Antonio, TX, The Toxicologist, Oxford University Press, 1700, 2018.
  89. Corcoran GB, Bobst SM, Kamendi H, Willett KM, Fox DA, and Plunkett LK: Cannabidiol Science, Safety and Society: Where do we stand? Society of Toxicology 59th Annual Meeting and ToxExpo, The Toxicologist Oxford University Press, 3269, 2020 
  90. Corcoran GB, Bobst SM, Kamendi H, Kaplan B, Willett KM, Fox DA, and Plunkett LK: Cannabidiol Science, Safety and Society: Where do we stand? 60th Annual Meeting of the Society of Toxicology, Orlando, FL The Toxicologist, 1304, 2021 
  91. Bobst SM, Corcoran GB, Willett KM, Gaston T and Plunkett LK: Cannabidiol Science, Safety and Society: Where do we stand? Annual Meeting of the American Association for the Advancement of Science, 2021